Skip to main content
. 2023 Nov 15;32(1):139–150. doi: 10.32604/or.2023.030190

Table 2. Cell cycle and sub-G1 distributions shown in Fig. 1D.

Cisplatin (μM)
0 10 30
Sub-G1 G1 S G2/M Sub-G1 G1 S G2/M Sub-G1 G1 S G2/M
LoVo 0.6% 64.0% 18.8% 16.8% 3.4% 11.2% 17.9% 67.0% 49.3% 33.2% 8.5% 9.2%
cisplatinr/LoVo #10 0.5% 67.7% 15.2% 16.8% 3.9% 15.7% 21.4% 59.5% 6.8% 39.9% 26.3% 27.4%
#19 0.4% 65.8% 16.3% 17.6% 5.3% 15.0% 26.8% 53.5% 13.4% 43.9% 19.8% 23.2%
#54 1.3% 73.4% 11.7% 14.0% 1.9% 25.7% 13.9% 58.9% 3.1% 49.8% 22.3% 25.2%